跳至主要内容
临床试验/ACTRN12617000079347
ACTRN12617000079347已完成4 期

A cluster randomised controlled trial to assess the impact of meningococcal B vaccine 4CMenB on nasopharyngeal carriage of N. Meningitidis in adolescents in South Australia

The University of Adelaide0 个研究点目标入组 34,489 人开始时间: 2017年1月16日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
34,489

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
14 Years 至 100 Years(—)
性别
All

入选标准

  • 1. South Australian secondary school students in years 10, 11, and 12 in 2017
  • 2. Written parental consent for those under the age of 18
  • 3. Written student consent-assent for those under the age of 18 (or if 18 years old and older consent for themselves)
  • 4. Available at school for at least the first pharyngeal swab

排除标准

  • 1. Previous recipient of 4CMenB vaccine (Bexsero)
  • 2. Known pregnancy
  • 3. Anaphylaxis following any component of the 4CMenB vaccine

研究者

相似试验

South Australian Meningococcal B Vaccine Herd... | 临床试验